The incident cases of obesity in India are expected to increase from 27,295 in 2021 to 34,273 in 2031, ranking it as the highest among the five major markets* in the Asia-Pacific (APAC) region
Lifestyle disorders pose an escalating health challenge in India due to the adoption of modernised lifestyles. Obesity stands as a prominent concern, correlating with the onset of various diseases across diverse age demographics.
Emphasising the severity of this issue, there is a pressing demand for heightened awareness regarding weight management and the fulfillment of unmet needs within the realm of obesity intervention, says GlobalData
According to GlobalData’s Pharmaceutical Intelligence Center, the incident cases of obesity in India are expected to increase from 27,295 in 2021 to 34,273 in 2031, ranking it as the highest among the five major markets* in the Asia-Pacific (APAC) region. China’s annual growth rate (AGR) stands at 0.12 per cent, contrasting sharply with India’s AGR of 2.56 per cent. This notable difference represents a 21-fold increase in India’s AGR compared to China’s between 2021 and 2031.
Srija Chilamula, Pharma Analyst, GlobalData comments, “Weight loss drugs have become increasingly popular in recent years as people seek effective and easy alternatives to manage their weight. In India, where obesity cases are steadily increasing with limited options, there is a growing interest in finding effective therapies. The two popular therapies Wegovy and Zepbound are expected to garner attention in the country.”
Chilamula concludes, “Obesity poses significant health challenges, and addressing these issues requires access to effective treatments and patient education to switch to a healthy lifestyle. The introduction of the novel weight loss drugs will gain momentum in India and holds great significance, as it broadens the treatment options for obese patients who have access to limited approved therapies, offering hope to improve their health and well-being.”
*Five major markets: Australia, China, India, Japan, South Korea.